Medicure (CVE:MPH) Share Price Passes Below 200-Day Moving Average – What’s Next?

Medicure Inc. (CVE:MPH)’s share price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of C$1.01 and traded as low as C$0.98. Medicure shares last traded at C$0.98, with a volume of 1,506 shares.

Medicure Stock Down 1.0 %

The company has a current ratio of 1.87, a quick ratio of 1.29 and a debt-to-equity ratio of 2.06. The firm’s 50 day simple moving average is C$0.93 and its two-hundred day simple moving average is C$1.01. The firm has a market cap of C$10.23 million, a price-to-earnings ratio of -3.92 and a beta of 0.90.

About Medicure

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.